Jane Street’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7K Sell
15,300
-4,200
-22% -$6.94K ﹤0.01% 11195
2025
Q4
$43.1K Buy
+19,500
New +$36.7K ﹤0.01% 10551
2025
Q2
Sell
-154,300
Closed -$1.04M 10361
2025
Q1
$1.04M Hold
154,300
﹤0.01% 5502
2024
Q4
$1.05M Buy
154,300
+7,500
+5% +$49.4K ﹤0.01% 5297
2024
Q3
$1.22M Buy
+146,800
New +$1.06M ﹤0.01% 5486

Other funds holding LUNG

Jane Street's LUNG Position: Q1 2026 in Review

Jane Street reduced its Pulmonx (LUNG) stake by 19% in Q1 2026, selling an estimated $52.4K and leaving 133,270 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #10277.

Jane Street first reported a position in LUNG in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.55M in Q1 2022. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Jane Street held 133,270 shares of Pulmonx worth $172K as of Q1 2026.
  • Jane Street sold 31,701 Pulmonx shares in Q1 2026, an estimated $52.4K.
  • Pulmonx made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10277 holding.
  • Jane Street first reported a position in Pulmonx in Q1 2021 and has held it in 17 quarters since.
  • Jane Street's Pulmonx position peaked at $1.55M in Q1 2022.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.